Eagle Point Credit Company Inc. 7.75% Series B Term Preferred Stock due 2026
ECCB
ECCB was delisted on the 25th of February, 2022.
0 hedge funds and large institutions have $0 invested in Eagle Point Credit Company Inc. 7.75% Series B Term Preferred Stock due 2026 in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $257K → $0 (-$257K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IR
IAT Reinsurance
New York
|
-$257K |
ECCB Hedge Fund Activity: Q2 2021 in Review
0 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Eagle Point Credit Company Inc. 7.75% Series B Term Preferred Stock due 2026 (ECCB) for Q2 2021, worth a combined $0 — down 100% from $257K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ECCB and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was IAT Reinsurance, exiting entirely with an estimated $257K sold.
- 0 institutional investors held Eagle Point Credit Company Inc. 7.75% Series B Term Preferred Stock due 2026 (ECCB) as of Q2 2021, down from 1 in Q1 2021.
- Funds reported $0 of Eagle Point Credit Company Inc. 7.75% Series B Term Preferred Stock due 2026 stock for Q2 2021, down 100% quarter-over-quarter.
- 0 funds opened new Eagle Point Credit Company Inc. 7.75% Series B Term Preferred Stock due 2026 positions in Q2 2021 and 1 closed out, a net change of -1 holder.
- The largest Eagle Point Credit Company Inc. 7.75% Series B Term Preferred Stock due 2026 seller in Q2 2021 was IAT Reinsurance, an estimated $257K sold.
Based on aggregated 13F filings for Q2 2021.